No Data
No Data
Express News | Pfizer : Barclays Raises Target Price to $30 From $28
Barclays Maintains Pfizer(PFE.US) With Hold Rating, Raises Target Price to $30
Barclays analyst Gena Wang maintains $Pfizer(PFE.US)$ with a hold rating, and adjusts the target price from $28 to $30.According to TipRanks data, the analyst has a success rate of 46.2% and a total
J.P. Morgan Maintains Pfizer(PFE.US) With Hold Rating, Maintains Target Price $30
J.P. Morgan analyst Chris Schott maintains $Pfizer(PFE.US)$ with a hold rating, and maintains the target price at $30.According to TipRanks data, the analyst has a success rate of 50.2% and a total
Evotec, Pfizer Team Up for Early Drug Discovery for Metabolic, Infectious Diseases
Evotec (EVT.F) and pharmaceutical company Pfizer (PFE.F) entered into a multi-year master research collaboration and option and license agreement to conduct early discovery research for metabolic
Express News | Evotec SE Shares up 2.3% After Collaboration Agreement With Pfizer
J.P. Morgan Keeps Their Hold Rating on Pfizer (PFE)
Sung Jun Lee : DJT was set nasdac short selling so not rise up.
may be July will rise up ,Biden will down ....
Sung Jun Lee : DJT is auto too much short selling nasdac.Biden out of presiden and set short selling finished and rise up.
Ultratech Sung Jun Lee: you like trump so much but you understand he creates a lot of market crashes. as an investor you do not want him unless shorting. the stock market hates uncertainty more than bad news. Trump brings a lot of uncertainty. youtube "trump lashes out at big tech"